FULL TEST Ri
Ri
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
Ri Ri
Ri
Ri Ri
D PRACTICE A PRACTICAL APPROACH 5TH
Ri Ri Ri Ri Ri
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
Ri Ri Ri Ri Ri Ri
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
Ri Ri Ri Ri Ri
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
Ri Ri Ri Ri Ri Ri Ri Ri Ri
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
Ri Ri Ri Ri Ri Ri Ri
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
Ri R i Ri R i Ri R i
For more Test banks, ATI, HES! exams, and more contact us.
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
, Table of content Ri Ri
Chapter I Issues for the Practitioner in Drug Therapy
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Ri Ri Ri Ri Ri Ri Ri Ri R
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Ch
i Ri R i Ri Ri Ri R i Ri Ri R i Ri Ri
apter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Ch
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
apter 5 Pharmacotherapy Principles in Older Adults
Ri Ri Ri Ri Ri Ri
Chapter 6 Principles of Antimicrobial Therapy Chapt
Ri Ri Ri Ri Ri Ri
er 7 Pharmacogenomies
Ri Ri
Chapter 8 The Economics of Pharmacotherapeutics C
Ri Ri Ri Ri Ri Ri
hapter 9 Pharmacotherapy of Pain Management
Ri Ri Ri Ri Ri
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 11 Cannabis and Pain Management
Ri Ri Ri Ri Ri
Chapter 12 Contact Dermatitis Ri Ri Ri
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 14 Psoriasis Ri Ri
Chapter I5 Acne Vulgaris and Rosacea Chapt
Ri Ri Ri Ri Ri Ri
er 16 Ophthalmic Disorders
Ri Ri Ri
Chapter I7 Otitis Media and Otitis Externa C
Ri Ri Ri Ri Ri Ri Ri
hapter I8 Hypertension Ri Ri
Chapter I9 Hyperlipidemia Ri Ri
Chapter 20 Chronic Stable Angina and Myocardial Infarction
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 2I Heart Failure Ri Ri Ri
Chapter 22 Arrhythmias Ri Ri
Chapter 23 Respiratory Infections Ri Ri Ri
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chap
Ri Ri Ri Ri Ri Ri Ri Ri
ter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapte
Ri Ri Ri Ri Ri Ri Ri Ri
r 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapte
Ri Ri Ri Ri Ri Ri Ri Ri Ri
r 27 Liver Diseases
Ri Ri Ri
Chapter 28 Urinary Tract Infection Ri Ri Ri Ri
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapt
Ri Ri Ri Ri Ri Ri Ri
er 30 Overactive Bladder
Ri Ri Ri
Chapter 3I Sexually Transmitted Infections
Ri Ri Ri Ri
Chapter 32 Osteoarthritis and Gout Chap
Ri Ri Ri Ri Ri Ri
ter 33 Osteoporosis
Ri Ri
Chapter 34 Rheumatoid Arthritis Ri Ri Ri Ri
Chapter 35 Headaches Ri Ri
Chapter 36 Seizure Disorders Ri Ri Ri Ri
Chapter 37 Alzheimer's Disease Ri Ri Ri R i
Chapter 38 Parkinson's Diseas Ri Ri Ri
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 40 Anxiety Disorders Ri Ri Ri
Chapter 41 Sleep Disorders Ri R i R i
Chapter 42 Attention Deficit Hyperactivity Disorder
Ri Ri Ri Ri Ri Ri
Chapter 43 Substance Use Disorders Ri Ri Ri Ri
Chapter 44 Diabetes Mellitus Ri Ri Ri
Chapter 45 Thyroid and Parathyroid Disorders
Ri Ri Ri Ri Ri
,Chapter 46 Allergies and Allergic Reactions
Ri Ri Ri Ri Ri
Chapter 47 Human Immunodeficiency Viru
Ri Ri Ri Ri Ri
s Chapter 48 Organ Transplantation
Ri Ri Ri Ri
Chapter 49 Thromboembolic Disorders Ch
Ri Ri Ri Ri
apter 50 Anemias
Ri Ri
Chapter 5l Immunizations Cha
Ri Ri Ri
pter 52 Smoking Cessation Cha
Ri Ri Ri Ri
pter 53 Weight Loss Chapter 5
Ri Ri Ri Ri Ri
4 Contraception
Ri
Chapter 55 Menopause Ri Ri
Chapter 56 Vaginitis Ri Ri
, Ri
R i Ri
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
Ri Ri Ri Ri Ri Ri Ri Ri
MULTIPLE CHOICE Ri
1. Nurse practitioner prescriptive authority is regulated by:
Ri Ri Ri Ri Ri Ri
A. The National Council of State Boards of Nursing
Ri Ri Ri Ri Ri Ri Ri
B. The U.S. Drug Enforcement Administration
Ri Ri Ri Ri
C. The State Board of Nursing for each state
Ri Ri Ri Ri Ri Ri Ri
D. The State Board of Pharmacy
Ri Ri Ri Ri
ANS: C R i PTS: R i 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
Ri Ri Ri Ri Ri Ri Ri
A. The National Council of State Boards of Nursing
Ri Ri Ri Ri Ri Ri Ri
B. The U.S. Drug Enforcement Administration
Ri Ri Ri Ri
C. The State Board of Nursing
Ri Ri Ri Ri
D. The State Board of Medical Examiners
Ri Ri Ri Ri Ri
ANS: D R i PTS: R i 1
3. Clinical judgment in prescribing includes:
Ri Ri Ri Ri
A. Factoring in the cost to the patient of the medication prescribed
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
B. Always prescribing the newest medication available for the disease process
Ri Ri Ri Ri Ri Ri Ri Ri Ri
C. Handing out drug samples to poor patients
Ri Ri Ri Ri Ri Ri
D. Prescribing all generic medications to cut costs Ri Ri Ri Ri Ri Ri
ANS: A R i PTS: R i 1
4. Criteria for choosing an effective drug for a disorder include:
Ri Ri Ri Ri Ri Ri Ri Ri Ri
A. Asking the patient what drug they think would work best for them
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
B. Consulting nationally recognized guidelines for disease management
Ri Ri Ri Ri Ri Ri
C. Prescribing medications that are available as samples before writing a prescription
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
Ri Ri Ri Ri Ri Ri Ri
prescribing
Ri
ANS: B R i PTS: R i 1
5. Nurse practitioner practice may thrive under health-care reform due to:
Ri Ri Ri Ri Ri Ri Ri Ri Ri
A. The demonstrated ability of nurse practitioners to control costs and improve patien
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
t outcomes
Ri
B. The fact that nurse practitioners will be able to practice independently
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
C. The fact that nurse practitioners will have full reimbursement under health-
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
care reform Ri
D. The ability to shift accountability for Medicaid to the state level
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
ANS: A R i PTS: R i 1
Ri
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
Ri Ri
Ri
Ri Ri
D PRACTICE A PRACTICAL APPROACH 5TH
Ri Ri Ri Ri Ri
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
Ri Ri Ri Ri Ri Ri
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
Ri Ri Ri Ri Ri
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
Ri Ri Ri Ri Ri Ri Ri Ri Ri
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
Ri Ri Ri Ri Ri Ri Ri
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
Ri R i Ri R i Ri R i
For more Test banks, ATI, HES! exams, and more contact us.
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
, Table of content Ri Ri
Chapter I Issues for the Practitioner in Drug Therapy
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
Ri Ri Ri Ri Ri Ri Ri Ri R
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Ch
i Ri R i Ri Ri Ri R i Ri Ri R i Ri Ri
apter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Ch
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
apter 5 Pharmacotherapy Principles in Older Adults
Ri Ri Ri Ri Ri Ri
Chapter 6 Principles of Antimicrobial Therapy Chapt
Ri Ri Ri Ri Ri Ri
er 7 Pharmacogenomies
Ri Ri
Chapter 8 The Economics of Pharmacotherapeutics C
Ri Ri Ri Ri Ri Ri
hapter 9 Pharmacotherapy of Pain Management
Ri Ri Ri Ri Ri
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 11 Cannabis and Pain Management
Ri Ri Ri Ri Ri
Chapter 12 Contact Dermatitis Ri Ri Ri
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 14 Psoriasis Ri Ri
Chapter I5 Acne Vulgaris and Rosacea Chapt
Ri Ri Ri Ri Ri Ri
er 16 Ophthalmic Disorders
Ri Ri Ri
Chapter I7 Otitis Media and Otitis Externa C
Ri Ri Ri Ri Ri Ri Ri
hapter I8 Hypertension Ri Ri
Chapter I9 Hyperlipidemia Ri Ri
Chapter 20 Chronic Stable Angina and Myocardial Infarction
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 2I Heart Failure Ri Ri Ri
Chapter 22 Arrhythmias Ri Ri
Chapter 23 Respiratory Infections Ri Ri Ri
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chap
Ri Ri Ri Ri Ri Ri Ri Ri
ter 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapte
Ri Ri Ri Ri Ri Ri Ri Ri
r 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapte
Ri Ri Ri Ri Ri Ri Ri Ri Ri
r 27 Liver Diseases
Ri Ri Ri
Chapter 28 Urinary Tract Infection Ri Ri Ri Ri
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapt
Ri Ri Ri Ri Ri Ri Ri
er 30 Overactive Bladder
Ri Ri Ri
Chapter 3I Sexually Transmitted Infections
Ri Ri Ri Ri
Chapter 32 Osteoarthritis and Gout Chap
Ri Ri Ri Ri Ri Ri
ter 33 Osteoporosis
Ri Ri
Chapter 34 Rheumatoid Arthritis Ri Ri Ri Ri
Chapter 35 Headaches Ri Ri
Chapter 36 Seizure Disorders Ri Ri Ri Ri
Chapter 37 Alzheimer's Disease Ri Ri Ri R i
Chapter 38 Parkinson's Diseas Ri Ri Ri
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
Ri Ri Ri Ri Ri Ri Ri Ri
Chapter 40 Anxiety Disorders Ri Ri Ri
Chapter 41 Sleep Disorders Ri R i R i
Chapter 42 Attention Deficit Hyperactivity Disorder
Ri Ri Ri Ri Ri Ri
Chapter 43 Substance Use Disorders Ri Ri Ri Ri
Chapter 44 Diabetes Mellitus Ri Ri Ri
Chapter 45 Thyroid and Parathyroid Disorders
Ri Ri Ri Ri Ri
,Chapter 46 Allergies and Allergic Reactions
Ri Ri Ri Ri Ri
Chapter 47 Human Immunodeficiency Viru
Ri Ri Ri Ri Ri
s Chapter 48 Organ Transplantation
Ri Ri Ri Ri
Chapter 49 Thromboembolic Disorders Ch
Ri Ri Ri Ri
apter 50 Anemias
Ri Ri
Chapter 5l Immunizations Cha
Ri Ri Ri
pter 52 Smoking Cessation Cha
Ri Ri Ri Ri
pter 53 Weight Loss Chapter 5
Ri Ri Ri Ri Ri
4 Contraception
Ri
Chapter 55 Menopause Ri Ri
Chapter 56 Vaginitis Ri Ri
, Ri
R i Ri
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
Ri Ri Ri Ri Ri Ri Ri Ri
MULTIPLE CHOICE Ri
1. Nurse practitioner prescriptive authority is regulated by:
Ri Ri Ri Ri Ri Ri
A. The National Council of State Boards of Nursing
Ri Ri Ri Ri Ri Ri Ri
B. The U.S. Drug Enforcement Administration
Ri Ri Ri Ri
C. The State Board of Nursing for each state
Ri Ri Ri Ri Ri Ri Ri
D. The State Board of Pharmacy
Ri Ri Ri Ri
ANS: C R i PTS: R i 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
Ri Ri Ri Ri Ri Ri Ri
A. The National Council of State Boards of Nursing
Ri Ri Ri Ri Ri Ri Ri
B. The U.S. Drug Enforcement Administration
Ri Ri Ri Ri
C. The State Board of Nursing
Ri Ri Ri Ri
D. The State Board of Medical Examiners
Ri Ri Ri Ri Ri
ANS: D R i PTS: R i 1
3. Clinical judgment in prescribing includes:
Ri Ri Ri Ri
A. Factoring in the cost to the patient of the medication prescribed
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
B. Always prescribing the newest medication available for the disease process
Ri Ri Ri Ri Ri Ri Ri Ri Ri
C. Handing out drug samples to poor patients
Ri Ri Ri Ri Ri Ri
D. Prescribing all generic medications to cut costs Ri Ri Ri Ri Ri Ri
ANS: A R i PTS: R i 1
4. Criteria for choosing an effective drug for a disorder include:
Ri Ri Ri Ri Ri Ri Ri Ri Ri
A. Asking the patient what drug they think would work best for them
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
B. Consulting nationally recognized guidelines for disease management
Ri Ri Ri Ri Ri Ri
C. Prescribing medications that are available as samples before writing a prescription
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
Ri Ri Ri Ri Ri Ri Ri
prescribing
Ri
ANS: B R i PTS: R i 1
5. Nurse practitioner practice may thrive under health-care reform due to:
Ri Ri Ri Ri Ri Ri Ri Ri Ri
A. The demonstrated ability of nurse practitioners to control costs and improve patien
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
t outcomes
Ri
B. The fact that nurse practitioners will be able to practice independently
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
C. The fact that nurse practitioners will have full reimbursement under health-
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
care reform Ri
D. The ability to shift accountability for Medicaid to the state level
Ri Ri Ri Ri Ri Ri Ri Ri Ri Ri
ANS: A R i PTS: R i 1